Switch to:
GuruFocus has detected 3 Warning Signs with Biomarin Pharmaceutical Inc $BMRN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/EBITDA
-28.17 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Biomarin Pharmaceutical Inc's enterprise value is $14,631 Mil. Biomarin Pharmaceutical Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2016 was $-519 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/EBITDA ratio for today is -28.17.

During the past 13 years, the highest EV/EBITDA Ratio of Biomarin Pharmaceutical Inc was 1532.30. The lowest was -25504.00. And the median was -75.15.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Biomarin Pharmaceutical Inc's stock price is $87.16. Biomarin Pharmaceutical Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2016 was $-2.96. Therefore, Biomarin Pharmaceutical Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Biomarin Pharmaceutical Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=14631.230/-519.46
=-28.17

Biomarin Pharmaceutical Inc's current Enterprise Value is $14,631 Mil.
Biomarin Pharmaceutical Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2016 was 86.69 (Dec. 2015 ) + -59.039 (Mar. 2016 ) + -518.587 (Jun. 2016 ) + -28.524 (Sep. 2016 ) = $-519 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Biomarin Pharmaceutical Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=87.16/-2.96
=

Biomarin Pharmaceutical Inc's share price for today is $87.16.
Biomarin Pharmaceutical Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was 0.44 (Dec. 2015 ) + -0.53 (Mar. 2016 ) + -2.61 (Jun. 2016 ) + -0.26 (Sep. 2016 ) = $-2.96.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Biomarin Pharmaceutical Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -101.90-326.1726.4558.82180.64-23,974.95-94.71-81.24-219.12-184.11

Biomarin Pharmaceutical Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2ebitda -81.97-207.79-219.12-208.56-151.60-72.82-184.11-140.27-22.99-29.89
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK